Pay in 4 interest-free payments of $6.09 Learn more
Ships within 48 hours · Estimated delivery Oct 1 - Oct 6
The therapy does not break the bank
We generated fully human antibodies to specifically block GDF8 (trevogrumab) and ActA (garetosmab), and showed that combining these blocking antibodies results in much greater increases in muscle than either of the antibodies individually, with dual blockade matching the muscle growth induced by broader ActRIIA/B pathway blockade in both mice and non-human primates (NHPs) 28,31
Survodutide has the potential to be the first global glucagon/GLP-1 dual agonist to help the more than 1 billion people living with obesity and MASH Survodutide has the potential to be the first global glucagon/GLP-1 dual agonist to help the more than 1 billion people living with obesity and MASH. Full data from the phase III trial will be presented at the American Diabetes Associations (ADA) 2026 Scientific Sessions in June
protection helps preserve strength
Consider: Maintaining a healthy weight
See our reconstitution guide for step-by-step instructions and use the dosage calculator for volume calculations
US$ 28.90
US$ 24.66
US$ 25.81
US$ 23.88
US$ 23.88
